Xin Lang Cai Jing·2025-08-12 01:26Group 1 - The core viewpoint of the news highlights the recent performance of Spring Medical, with a notable increase in stock price and trading volume on August 11, where the stock rose by 6.39% with a transaction amount of 91.98 million yuan [1] - On August 11, Spring Medical had a financing buy-in amount of 9.91 million yuan and a net financing buy of 599,100 yuan, indicating strong investor interest [1] - The total financing and securities balance for Spring Medical reached 38.27 million yuan, accounting for 0.55% of its market capitalization, which is above the 80th percentile of the past year, indicating a high level of financing activity [1] Group 2 - Spring Medical, established on February 12, 1998, specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - The company reported a revenue of 230 million yuan for the first quarter of 2025, reflecting a year-on-year growth of 3.6%, and a net profit of 58.07 million yuan, which is a 5.2% increase compared to the previous year [2] - As of March 31, 2025, the number of shareholders increased by 7.48% to 7,182, while the average circulating shares per person decreased by 6.99% to 11,063 shares [2] Group 3 - Spring Medical has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [3] - Among the top ten circulating shareholders, Zhonggeng Small Cap Value Stock holds 2.87 million shares, remaining unchanged, while Hong Kong Central Clearing Limited increased its holdings by 1.11 million shares to 2.29 million shares [3] - New shareholders include Ping An Low Carbon Economy Mixed A, which holds 1 million shares, while other funds have exited the top ten shareholder list [3]